SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, taking place July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, highlighted in multiple breakout sessions, and used in a live broadcast of a remote partial nephrectomy.
The live telesurgery will be performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi. This demonstration underscores the growing capabilities of remote robotic surgery and its potential to expand access to specialized care across distances.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in multiple sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. His involvement highlights the company’s focus on addressing key barriers to widespread adoption, including regulatory approval and cost.
As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform. These numbers reflect the system’s growing clinical footprint and its versatility across surgical specialties.
The presentation of the SSi Mantra at this major conference is significant for the industry as it demonstrates a viable alternative to established robotic systems, potentially increasing competition and lowering costs. For the reader, this news matters because it signals progress toward making robotic surgery more affordable and accessible globally. The company’s vision, as stated in the release, is to “make the benefits of robotic surgery affordable and accessible to a larger segment of the global population.”
Telesurgery, in particular, could revolutionize healthcare delivery by enabling expert surgeons to operate on patients in remote or underserved areas. The live broadcast of a remote partial nephrectomy at the meeting provides a real-world example of this technology in action. Moreover, the company’s focus on regulatory frameworks addresses a critical hurdle for the adoption of such technologies worldwide.
The event also serves as a platform for SS Innovations to showcase its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of procedures including cardiac surgery. As an American company headquartered in India, SS Innovations plans to expand its global presence, leveraging its technologically advanced, user-friendly, and cost-effective solutions.
The full press release is available at https://ibn.fm/YYYKE. For more information about SS Innovations, visit the InvestorBrandNetwork website. Forward-looking statements in this article are subject to risks and uncertainties as detailed in the company’s SEC filings.
